Cattlemen for Cancer Research (CCR) will hold its 20th annual auction in Bastrop, Texas, Saturday, Oct. 20, at the Hills Prairie Livestock Auction Company, 1177 Hwy. 304. Proceeds benefit the Michale E. Keeling Center for Comparative Medicine and Research at The University of Texas MD Anderson Cancer Center.
Guests can enjoy a complimentary lunch as well as a silent auction, a children's arts and crafts tent, a washer pitching...
A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related...
A Conversation With a Living Legend® in Dallas will honor PGA TOUR professional Jordan Spieth, Nov. 5 at the Hilton Anatole. CBS Sports'...
A drug revived by researchers at The University of Texas MD Anderson Cancer Center continues to provide unprecedented response rates among stage 4 non-small cell lung cancer patients with genetic mutations that have previously defied treatment.
Early results from a phase 2 clinical trial, reported today at the IASLC 19th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer, show 24...
The University of Texas MD Anderson Cancer Center today joined with more than 450 communities and institutions across the country in hosting...
In the largest study of long-term safety outcomes for patients with breast implants, researchers at The University of Texas MD Anderson Cancer...
Padmanee Sharma, M.D., Ph.D., is the 2018 recipient of the Julie and Ben Rogers Award for Excellence in Research at The University of Texas...
Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at The University of Texas MD Anderson...
Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor suppressor...
New research in women with HER2+ breast cancer found no difference in disease-free survival (DFS) and overall survival (OS) when receiving...
A drug revived by researchers at The University of Texas MD Anderson Cancer Center continues to provide high response rates among stage 4...